Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 97 filers reported holding Y-MABS THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $82,944 | -11.0% | 15,219 | +10.9% | 0.00% | – |
| Q2 2023 | $93,172 | +69.8% | 13,722 | +25.3% | 0.00% | – |
| Q1 2023 | $54,870 | -3.6% | 10,952 | -6.1% | 0.00% | – |
| Q4 2022 | $56,906 | -62.1% | 11,661 | +12.2% | 0.00% | – |
| Q3 2022 | $150,000 | -6.2% | 10,391 | -1.9% | 0.00% | – |
| Q2 2022 | $160,000 | -64.8% | 10,595 | -33.7% | 0.00% | – |
| Q3 2021 | $455,000 | +34.2% | 15,971 | +59.1% | 0.00% | – |
| Q2 2021 | $339,000 | +26.0% | 10,036 | +12.9% | 0.00% | – |
| Q1 2021 | $269,000 | -66.0% | 8,888 | -44.5% | 0.00% | -100.0% |
| Q4 2020 | $792,000 | +148.3% | 16,008 | +92.8% | 0.00% | – |
| Q3 2020 | $319,000 | -45.9% | 8,304 | -39.2% | 0.00% | -100.0% |
| Q2 2020 | $590,000 | – | 13,649 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 191,176 | $2,271,000 | 2.63% |
| Sofinnova Investments, Inc. | 2,194,278 | $26,068,000 | 1.98% |
| MPM BioImpact LLC | 443,702 | $5,271,000 | 1.42% |
| Soleus Capital Management, L.P. | 238,982 | $2,839,000 | 0.37% |
| Lombard Odier Asset Management (Switzerland) SA | 221,774 | $2,635,000 | 0.21% |
| Artal Group S.A. | 400,000 | $4,752,000 | 0.20% |
| Polar Capital Holdings Plc | 2,877,671 | $34,187,000 | 0.15% |
| ASHFORD CAPITAL MANAGEMENT INC | 106,770 | $1,268,000 | 0.14% |
| Cormorant Asset Management, LP | 150,000 | $1,782,000 | 0.14% |
| Virtus ETF Advisers LLC | 23,646 | $281,000 | 0.13% |